Castillejo, G., Bullo, M., Anguera, A., Escribano, J
For patients with type 2 diabetes, there is an increased risk of hypoglycaemia when Wegovy is used with insulin or sulfonylureas, and doses of these medications may need adjustment
,
Patients with Hashimoto's require careful monitoring as weight changes may affect levothyroxine requirements, and GLP-1 medications carry risks including pancreatitis and gallbladder disease
If you're on a GLP-1 medication for weight loss, such as Ozempic, Wegovy, or Mounjaro, your eating habits may have changed to the point where dining out at restaurants feels less appealing
You wouldnt know it from the most cheerleading business coverage of GLP-1s, but the drugs revenue growth has actually come in below market expectations in the last few years